Helix BioPharma Corp. to Present at the SNN Network Virtual Conference

RICHMOND HILL, ON / ACCESSWIRE / July 31, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced it will be presenting at the SNN Network Virtual Conference on Monday, August 3rd at 2:30 PM EDT. Dr. Heman Chao, Helix's Chief Executive Officer will be hosting the presentation and answering questions from attendees.

SNN Network Virtual Conference 2020
Date: Monday, August 3, 2020
Time: 2:30 PM Eastern Time
Webcast: https://www.webcaster4.com/Webcast/Page/2059/35940

To attend the SNN Network Virtual Investor Conference, register at https://conference.snn.network/signup. 1-on-1 meetings are available and will be scheduled and conducted via private, secure video conference through the conference event platform. Conference registration is required to book 1-on-1 investor meetings.

If you can't make the live presentation, Helix's webcast recording will be available directly on the conference event platform link under the tab "Schedule".

About Helix BioPharma Corp.

Helix BioPharma Corp. is an immuno-oncology company specializing in the field of cancer therapy. Helix is a biopharmaceutical company developing unique therapies in the field of immuno-oncology, for the prevention and treatment of cancer, based on its proprietary technology platform DOS47. Helix is currently listed on the TSX under the symbol "HBP". For more information: https://www.helixbiopharma.com

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN.Network.

Investor Relations

SOURCE: Helix BioPharma Corp.